Effects of drug and hazardous alcohol use on having a detectable HIV viral load: An adherence mediation analysis

Agudelo, 2015, Alcohol and cannabinoids differentially affect HIV infection and function of human monocyte-derived dendritic cells (MDDC), Frontiers in Microbiology, 6, 1452, 10.3389/fmicb.2015.01452 Amedee, 2014, Chronic alcohol abuse and HIV disease progression: Studies with the non-human primate model, Current HIV Research, 12, 243, 10.2174/1570162X12666140721115717 Amico, 2006, Visual analog scale of ART adherence: Association with 3-day self-report and adherence barriers, Journal of Acquired Immune Deficiency Syndromes, 42, 455, 10.1097/01.qai.0000225020.73760.c2 Azzoni, 2020, Effect of opioid use on immune activation and HIV persistence on ART, Journal of Neuroimmune Pharmacology, 15, 643, 10.1007/s11481-020-09959-y Buch, 2020, Opioid-Mediated HIV-1 Immunopathogenesis, Journal of Neuroimmune Pharmacology, 15, 628, 10.1007/s11481-020-09960-5 Bagasra, 1989, Effects of alcohol ingestion on in vitro susceptibility of peripheral blood mononuclear cells to infection with HIV and of selected T-cell functions, Alcoholism, Clinical and Experimental Research, 13, 636, 10.1111/j.1530-0277.1989.tb00396.x Bradley, 2007, AUDIT-C as a brief screen for alcohol misuse in primary care, Alcoholism, Clinical and Experimental Research, 31, 1208, 10.1111/j.1530-0277.2007.00403.x Bonn-Miller, 2014, Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms, Journal of Behavioral Medicine, 37, 1, 10.1007/s10865-012-9458-5 Chander, 2006, Hazardous alcohol use: A risk factor for nonadherence and lack of suppression in HIV infection, Journal of Acquired Immune Deficiency Syndromes, 43, 411, 10.1097/01.qai.0000243121.44659.a4 Christopoulos, K.A., Grochowski, J., Mayorga-Munoz, F., Hickey, M.D., Imbert, E., Szumowski, J.D., Dilworth, S., Oskarsson, J., Shiels, M., Havlir, D., Gandhi, M., (2022). First demonstration project of long-acting injectable antiretroviral therapy for persons with and without detectable HIV viremia in an urban HIV clinic. Clinical Infectious Disease 2022 Aug 1:ciac631. Epub ahead of print. Conen, 2009, Self-reported alcohol consumption and its Association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study, Antiviral Therapy, 14, 349, 10.1177/135965350901400303 Conigliaro, 2003, Veterans Aging Cohort 3-Site S. How harmful is hazardous alcohol use and abuse in HIV infection: Do health care providers know who is at risk?, Journal of Acquired Immune Deficiency Syndromes, 33, 521, 10.1097/00126334-200308010-00014 Cook, 2017, Alcohol consumption patterns and HIV viral suppression among persons receiving HIV care in Florida: An observational study, Addiction Science & Clinical Practice, 12, 22, 10.1186/s13722-017-0090-0 Desai, 2020, An update on drug-drug interactions between antiretroviral therapies and drugs of abuse in HIV systems, Expert Opinion on Drug Metabolism & Toxicology, 16, 1005, 10.1080/17425255.2020.1814737 Emsley, R.A., Liu, H., Dunn, G., L., V., VanderWeele, T.J. (2013). PARAMED: Causal mediation analysis using parametric models. Eisinger, 2019, HIV viral load and transmissibility of HIV infection: Undetectable equals untransmittable, Journal of the American Medical Association, 321, 451, 10.1001/jama.2018.21167 Feelemyer, 2020, Associations between methamphetamine use and lack of viral suppression among a cohort of HIV-positive persons who inject drugs in Hai Phong, VietnamAIDS, 34, 1875 Feldman, 2013, Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV, AIDS and Behavior, 17, 307, 10.1007/s10461-012-0326-7 Feldman, 2015, Crystal methamphetamine use and HIV medical outcomes among HIV-infected men who have sex with men accessing support services in New York, Drug and Alcohol Dependence, 147, 266, 10.1016/j.drugalcdep.2014.09.780 Gonzalez, 2011, Substance use: Impact on adherence and HIV medical treatment, Current HIV/AIDS Reports, 8, 223, 10.1007/s11904-011-0093-5 Hendershot, 2009, Alcohol use and antiretroviral adherence: Review and meta-analysis, Journal of Acquired Immune Deficiency Syndromes, 52, 180, 10.1097/QAI.0b013e3181b18b6e Jiang, 2016, In vivo effects of methamphetamine on HIV-1 replication: A population-based study, Drug and Alcohol Dependence, 159, 246, 10.1016/j.drugalcdep.2015.12.027 Kahler, 2017, Direct and indirect effects of heavy alcohol use on clinical outcomes in a longitudinal study of HIV patients on ART, AIDS and Behavior, 21, 1825, 10.1007/s10461-016-1474-y Khalili, 2021, Validity of self-reported substance use: Research setting versus primary health care setting. Subst Abuse Treat Prev, Policy, 14;16(1):66 Lai, 2020, Methamphetamine use associated with nonadherence to antiretroviral treatment in men who have sex with men, Scientific Reports, 10, 7131, 10.1038/s41598-020-64069-2 Lee, 2021, A guideline for reporting mediation analyses of randomized trials and observational studies: The AGReMA statement, Journal of the American Medical Association, 326, 1045, 10.1001/jama.2021.14075 Liu, 2012, Classification accuracy and cut point selection, Statistics in Medicine, 15;31, 2676, 10.1002/sim.4509 Massanella, 2015, Methamphetamine use in HIV-infected individuals affects T-cell function and viral outcome during suppressive antiretroviral therapy, Scientific Reports, 5, 13179, 10.1038/srep13179 Molina, 2015, Behavioral, metabolic, and immune consequences of chronic alcohol or cannabinoids on HIV/AIDs: Studies in the non-human primate SIV model, Journal of Neuroimmune Pharmacology, 10, 217, 10.1007/s11481-015-9599-8 Napuri, 2013, Cocaine enhances HIV-1 infectivity in monocyte derived dendritic cells by suppressing microRNA-155, PLoS One1, 8, e83682, 10.1371/journal.pone.0083682 Nolan, 2017, HIV-infected individuals who use alcohol and other drugs, and virologic suppression, AIDS Care, 29, 1129, 10.1080/09540121.2017.1327646 O'Laughlin, 2018, Cross-sectional analysis of longitudinal mediation processes, Multivariate Behav Res., 53, 375, 10.1080/00273171.2018.1454822 Palepu, 2003, Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy, Journal of Urban Health, 80, 667, 10.1093/jurban/jtg073 Parsons, 2008, Medication adherence mediates the relationship between adherence self-efficacy and biological assessments of HIV health among those with alcohol use disorders, AIDS and Behavior, 12, 95, 10.1007/s10461-007-9241-8 Prasad, 2019, Methamphetamine functions as a novel CD4(+) T-cell activator via the sigma-1 receptor to enhance HIV-1 infection, Scientific Reports, 9, 958, 10.1038/s41598-018-35757-x Rasbach, 2013, Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: Use of a rapid screening tool during routine clinic visits, AIDS Care, 25, 109, 10.1080/09540121.2012.687814 Rosen, 2013, Association between use of specific drugs and antiretroviral adherence: Findings from MACH 14, AIDS and Behavior, 17, 142, 10.1007/s10461-011-0124-7 Saloner, 2020, Methamphetamine and cannabis: A tale of two drugs and their effects on HIV, brain, and behavior, Journal of Neuroimmune Pharmacology, 15, 743, 10.1007/s11481-020-09957-0 Simoni, 2006, Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management, AIDS and Behavior, 10, 227, 10.1007/s10461-006-9078-6 Stirratt, 2015, Self-report measures of medication adherence behavior: Recommendations on optimal use, Translational Behavioral Medicine, 5, 470, 10.1007/s13142-015-0315-2 Samet, 2005, A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems, Antiviral Therapy, 10, 83, 10.1177/135965350501000106 Socias, 2018, Substance use and adherence to antiretroviral therapy: What is known and what is unknown, Current Infectious Disease Reports, 20, 36, 10.1007/s11908-018-0636-7 Tyagi, 2016, Mechanisms of HIV transcriptional regulation by drugs of abuse, Current HIV Research, 14, 442, 10.2174/1570162X14666160324124736 Vanderweele, 2010, Odds ratios for mediation analysis for a dichotomous outcome, American Journal of Epidemiology, 172, 1339, 10.1093/aje/kwq332 Velloza, 2020, Alcohol use and antiretroviral therapy non-adherence among adults living with HIV/AIDS in Sub-Saharan Africa: A systematic review and meta-analysis, AIDS and Behavior, 24, 1727, 10.1007/s10461-019-02716-0 Vidot, 2017, Cannabis use, medication management and adherence among persons living with HIV, AIDS and Behavior, 21, 2005, 10.1007/s10461-017-1782-x Vidot, 2019, Brief report: Hazardous cannabis use and monocyte activation among methamphetamine users with treated HIV infection, Journal of Acquired Immune Deficiency Syndromes, 81, 361, 10.1097/QAI.0000000000002046 Vittinghoff, 2009, Sample size calculations for evaluating mediation, Statistics in Medicine, 28, 541, 10.1002/sim.3491 WHO Assist Working Group, 2002, The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Development, reliability and feasibility, Addiction, 97, 1183, 10.1046/j.1360-0443.2002.00185.x